Yes but the progress in getting the trials approved, started, and enrolled has been glacially slow. With such a great drug that so many top doctors know is effective. One has to ask why??? Surely someone at BIOMM or AEIH must know why. Aren’t they having regular meetings still?
Agreed - Approval and use of surprisingly safe Leronlimab could turn the Covid-19 from a killer to an inconvenience.
Upon positive result to covid-19 test (variant DOESN"T matter), begin with first 700 mg SubC injection, then one injection a week for four weeks. Can return to work when tests negative for virus, but should complete all four shots.
Some residual Covid results could manifest as time goes by necessitating another short course of Leronlimab injection(s).
Hardly anybody dies (from the covid or covid - immunological effects)
News 
Market Data 
Discover 
